Covid-19: Longer interval between Pfizer doses results in higher antibody levels, research finds
- 23 July 2021
- other
- review article
- Published by BMJ
- Vol. 374, n1875
- https://doi.org/10.1136/bmj.n1875
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit: